Broadsheet number 43: The role of the laboratory in the investigation and management of hyperuricemia

References

• Walmsley R, White G. Uric Acid. A Guide to Diagnostic Clinical Chemistry. Blackwell Scientific, Philadelphia 1992; 366–366, In
   Google Scholar
• Campion E, Glynn R, DeLabry L. Asymptomatic hyperuricemia. Am J Med 1987; 82: 421–426
   PubMedGoogle Scholar
• Kelley, W. Gout and other disorders of purine metabolism. Harrison's Principles of Internal Medicine, R Petersdorf, et al. McGraw-Hill, New York 1983; 517–517, In
   Google Scholar
• Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G. Age and sex specific paediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 Analyzer. Clin Chem 1988; 34: 1622–1625
   PubMedGoogle Scholar
• Pascual E. Hyperuricemia and gout. Curr Opin Rheumatol 1994; 6: 454–458
   PubMedGoogle Scholar
• Crook M. Hypouricemia in a hospital population. Scand J Clin Lab Invest 1993; 53: 883–885
   PubMed Web of Science ®Google Scholar
• Tietz NW. Appendix. Tietz Textbook of Clinical Chemistry2nd ed., C Burtis, E Ashwood. W.B. Saunders, Melbourne 1994; 2210–2210, In
   Google Scholar
• Lally E, Ho G, Kaplan S. The clinical spectrum of gouty arthritis in women. Arch Int Med 1986; 146: 2221–2226
   PubMedGoogle Scholar
• Emmerson BT, Nagel SL, Duffy, Martin NG. Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 1992; 51: 375–377
   PubMed Web of Science ®Google Scholar
• Simmonds HA, McBride MB, Hatfield PJ, Graham R, McCaskey J, Jackson M. Polynesian women are also at risk for hyperuricemia and gout because of a genetic defect in renal urate handling. Br J Rheumatol 1994; 33: 932–937
   PubMedGoogle Scholar
• Wallace S, Robinson H, Masi A. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895–900
   PubMed Web of Science ®Google Scholar
• Corkill M. Gout. NZ Med J 1994; 107: 337–339
   PubMedGoogle Scholar
• Snaith M. Gout, hyperuricemia, and crystalline arthritis. BMJ 1995; 310: 521–526
   PubMedGoogle Scholar
• Calabrese G, Simmonds H, Cameron J. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes. Qu J Med 1990; 75: 441–450
   PubMedGoogle Scholar
• Moro, F, Ogg, C, Simmonds, H, Cameron, J, Chantler, C, McBride, M, et al. Familial gouty nephropathy with renal urate hypoexcretion preceding renal disease. Clin Nephrol 1991; 35: 263–269
   PubMedGoogle Scholar
• Dieppe P. Investigation and management of gout in the young and elderly. Ann Rheum Dis 1991; 50: 263–266
   PubMedGoogle Scholar
• Sacki, A, Hosoya, T, Okabe, H, Saji, M, Tabe, A, Ichida, K, et al. Newly discovered familial juvenile gouty nephropathy in a Japanese family. Nephron 1995; 70: 359–366
   PubMedGoogle Scholar
• Vecchio PC, Emmerson BT. Gout due to renal disease. Br J Rheumatol 1992; 31: 63–65
   PubMedGoogle Scholar
• Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78: 25–29
   PubMed Web of Science ®Google Scholar
• Tinahones, FJ, Collantes, E, C-Soriguer, FJ, Gonzalez-Ruiz, A, Pineda, M, Anon, J, et al. Increased VLDL levels and diminished renal excretion of uric acid in hyperuricemic-hypertriglyceridemic patients. Br J Rheumatol 1995; 34: 920–924
   PubMedGoogle Scholar
• Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Higashino K. Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridemia. Ann Rheum Dis 1995; 54: 351–354
   PubMed Web of Science ®Google Scholar
• Tykarski A, Oko-Sarnowska Z, Skoluda A. Uric acid and hypertension. Pol Arch Med. 1991; 86: 183–188
   PubMedGoogle Scholar
• Zavaroni, I, Mazza, S, Fantuzzi, M, Dall'Anglio, E, Bonora, E, Delsignore, R, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricemia. J Intern Med 1993; 234: 25–30
   PubMed Web of Science ®Google Scholar
• Eastmond C, Garton M, Robins S, Riddoch S. The effects of alcoholic beverages on urate metabolism in gout sufferers. Br J Rheumatol 1995; 34: 756–759
   PubMedGoogle Scholar
• Davidson-Mundt A, Luder A, Green C. Hyperuricemia in mediumchain acyl-coenzyme A dehydrogenase deficiency. J Pediatr 1992; 120: 444–446
   PubMedGoogle Scholar
• Emmerson B. The clinical role of allopurinol. Australian Prescriber 1992; 15: 77–79
   Google Scholar
• Emmerson B. Identification of the cause of persistent hyperuricemia. Lancet 1991; 337: 1461–1464
   PubMed Web of Science ®Google Scholar